Despite companywide losses, Allergan's GI business is booming: 3 key notes

Despite falling revenues, Madison, N.J.-based Allergan's gastroenterology franchise grew by 8.2 percent in the third quarter, Market Realist reports.

Here's what you need to know.

1. The company's GI products include: Linzess, Viberzi, Asacol/Delzicol, Carafate/Sulcrate, Canasa/Salofalk and Zenpep.

2. In the third quarter, Allergan reported revenues of $431.4 million in 2016 compared to $398.6 million in 2015.

3. All Allergan GI products except Asacol/Delzicol reported positive growth.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers

Featured Podcast